Müller-Schilling, M., Strand, S., Hug, H., Heinemann, E., Walczak, H., Hofmann, W. J., . . . Galle, P. R. (1997). Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. The journal of clinical investigation, 99(3), . https://doi.org/10.1172/JCI119174
Chicago Style (17th ed.) CitationMüller-Schilling, Martina, Susanne Strand, Hubert Hug, Eva-Maria Heinemann, Henning Walczak, Walter J. Hofmann, Wolfgang Stremmel, Peter H. Krammer, and Peter R. Galle. "Drug-induced Apoptosis in Hepatoma Cells Is Mediated by the CD95 (APO-1/Fas) Receptor/ligand System and Involves Activation of Wild-type P53." The Journal of Clinical Investigation 99, no. 3 (1997). https://doi.org/10.1172/JCI119174.
MLA (9th ed.) CitationMüller-Schilling, Martina, et al. "Drug-induced Apoptosis in Hepatoma Cells Is Mediated by the CD95 (APO-1/Fas) Receptor/ligand System and Involves Activation of Wild-type P53." The Journal of Clinical Investigation, vol. 99, no. 3, 1997, https://doi.org/10.1172/JCI119174.